117 related articles for article (PubMed ID: 9585079)
1. MK-886, a leukotriene biosynthesis inhibitor, induces antiproliferative effects and apoptosis in HL-60 cells.
Dittmann KH; Mayer C; Rodemann HP; Petrides PE; Denzlinger C
Leuk Res; 1998 Jan; 22(1):49-53. PubMed ID: 9585079
[TBL] [Abstract][Full Text] [Related]
2. The effect of inhibition of leukotriene B4 release on lipopolysaccharide-induced production of neutrophil attractant/activation protein-1 (interleukin-8) by human alveolar macrophages.
Rankin JA; Harris P
Prostaglandins; 1993 Jan; 45(1):77-84. PubMed ID: 8380937
[TBL] [Abstract][Full Text] [Related]
3. Regulation of apoptosis in eicosapentaenoic acid-treated HL-60 cells.
Gillis RC; Daley BJ; Enderson BL; Kestler DP; Karlstad MD
J Surg Res; 2007 Jan; 137(1):141-50. PubMed ID: 17084410
[TBL] [Abstract][Full Text] [Related]
4. Acetyl-11-keto-beta-boswellic acid induces apoptosis in HL-60 and CCRF-CEM cells and inhibits topoisomerase I.
Hoernlein RF; Orlikowsky T; Zehrer C; Niethammer D; Sailer ER; Simmet T; Dannecker GE; Ammon HP
J Pharmacol Exp Ther; 1999 Feb; 288(2):613-9. PubMed ID: 9918566
[TBL] [Abstract][Full Text] [Related]
5. Potent antagonism of calmodulin activity in vitro, but lack of antiproliferative effects on keratinocytes by the novel leukotriene biosynthesis inhibitor MK-886.
Hegemann L; Hatzelmann A; Grewig S; Schmidt BH
Br J Dermatol; 1995 Jul; 133(1):41-7. PubMed ID: 7669639
[TBL] [Abstract][Full Text] [Related]
6. Role of 5-lipoxygenase pathway in the regulation of RAW 264.7 macrophage proliferation.
Nieves D; Moreno JJ
Biochem Pharmacol; 2006 Oct; 72(8):1022-30. PubMed ID: 16934759
[TBL] [Abstract][Full Text] [Related]
7. Reversal of human neutrophil survival by leukotriene B(4) receptor blockade and 5-lipoxygenase and 5-lipoxygenase activating protein inhibitors.
Lee E; Lindo T; Jackson N; Meng-Choong L; Reynolds P; Hill A; Haswell M; Jackson S; Kilfeather S
Am J Respir Crit Care Med; 1999 Dec; 160(6):2079-85. PubMed ID: 10588632
[TBL] [Abstract][Full Text] [Related]
8. Pre-treatment of HT-29 cells with 5-LOX inhibitor (MK-886) induces changes in cell cycle and increases apoptosis after photodynamic therapy with hypericin.
Kleban J; Szilárdiová B; Mikes J; Horváth V; Sacková V; Brezáni P; Hofmanová J; Kozubík A; Fedorocko P
J Photochem Photobiol B; 2006 Aug; 84(2):79-88. PubMed ID: 16545574
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of multiple oral doses of MK-0591, a 5-lipoxygenase-activating protein inhibitor.
Depré M; Friedman B; Van Hecken A; de Lepeleire I; Tanaka W; Dallob A; Shingo S; Porras A; Lin C; de Schepper PJ
Clin Pharmacol Ther; 1994 Jul; 56(1):22-30. PubMed ID: 8033491
[TBL] [Abstract][Full Text] [Related]
10. MK-886 enhances tumour necrosis factor-alpha-induced differentiation and apoptosis.
Stika J; Vondrácek J; Hofmanová J; Simek V; Kozubík A
Cancer Lett; 2006 Jun; 237(2):263-71. PubMed ID: 16039040
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of 5-lipoxygenase induces cell death in anti-inflammatory fatty acid-treated HL-60 cells.
Gillis RC; Daley BJ; Enderson BL; Karlstad MD
JPEN J Parenter Enteral Nutr; 2004; 28(5):308-14. PubMed ID: 15449569
[TBL] [Abstract][Full Text] [Related]
12. Biochemical activity, pharmacokinetics, and tolerability of MK-886, a leukotriene biosynthesis inhibitor, in humans.
Depre M; Friedman B; Tanaka W; Van Hecken A; Buntinx A; DeSchepper PJ
Clin Pharmacol Ther; 1993 May; 53(5):602-7. PubMed ID: 8387904
[TBL] [Abstract][Full Text] [Related]
13. Chronic leukotriene inhibition in the rat fails to modify the toxicological effects of a cyclooxygenase inhibitor.
Ford-Hutchinson AW; Tagari P; Ching SV; Anderson CA; Coleman JB; Peter CP
Can J Physiol Pharmacol; 1993; 71(10-11):806-10. PubMed ID: 8143238
[TBL] [Abstract][Full Text] [Related]
14. A new class of leukotriene biosynthesis inhibitor: the development of MK-0591.
Prasit P; Belley M; Blouin M; Brideau C; Chan C; Charleson S; Evans JF; Frenette R; Gauthier JY; Guay J
J Lipid Mediat; 1993; 6(1-3):239-44. PubMed ID: 8357985
[TBL] [Abstract][Full Text] [Related]
15. Increased cytosol Ca(2+) and type 1 programmed cell death in Bcl-2-positive U937 but not in Bcl-2-negative PC-3 and Panc-1 cells induced by the 5-lipoxygenase inhibitor MK 886.
Anderson KM; Alrefai WA; Dudeja PK; Jadko S; Bonomi P; Hu Y; Ou D; Harris JE
Prostaglandins Leukot Essent Fatty Acids; 2002 Apr; 66(4):443-52. PubMed ID: 12054916
[TBL] [Abstract][Full Text] [Related]
16. Reactive oxygen species and redox-induced programmed cell death due to MK 886: cells ("soil") "trump" agent ("seed").
Anderson KM; Rubenstein M; Alrefai WA; Dudeja P; Tsui P; Guinan P; Harris JE
In Vivo; 2005; 19(1):109-18. PubMed ID: 15796162
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and pharmacodynamic analysis of a novel leukotriene biosynthesis inhibitor, MK-0591, in healthy volunteers.
Uematsu T; Kanamaru M; Kosuge K; Hara K; Uchiyama N; Takenaga N; Tanaka W; Friedman BS; Nakashima M
Br J Clin Pharmacol; 1995 Jul; 40(1):59-66. PubMed ID: 8527269
[TBL] [Abstract][Full Text] [Related]
18. Effect of BI-L-239, A-64077 and MK-886 on leukotriene B4 synthesis by chopped guinea pig lung and on antigen-induced tracheal contraction in vitro.
Noonan TC; Jamieson-Leclercq T; Desai SN
Prostaglandins; 1992 Dec; 44(6):543-54. PubMed ID: 1335586
[TBL] [Abstract][Full Text] [Related]
19. Ionophore A23187-induced leukotriene biosynthesis in equine granulocytes-neutrophils, but not eosinophils require exogenous arachidonic acid.
Lindberg A; Tornhamre S; Mugnai S; Lindgren J
Biochim Biophys Acta; 1998 Mar; 1391(2):247-55. PubMed ID: 9555040
[TBL] [Abstract][Full Text] [Related]
20. Platelets, neutrophils, and vasoconstriction after arterial injury by angioplasty in pigs: effects of MK-886, a leukotriene biosynthesis inhibitor.
Provost P; Borgeat P; Merhi Y
Br J Pharmacol; 1998 Jan; 123(2):251-8. PubMed ID: 9489613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
